Ramona Stark

Title: Ramona Stark: Innovator in Antibody-Drug Conjugates

Introduction

Ramona Stark is a prominent inventor based in Au, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. Her innovative work has the potential to enhance therapeutic options in cancer treatment.

Latest Patents

Ramona Stark holds a patent for "Antibody-drug conjugates through specific linker oligopeptides." This invention relates to a method for generating an antibody-payload conjugate using microbial transglutaminase (MTG). The method involves conjugating a linker to a Gln residue in an antibody, utilizing a specific structure that includes various chemical spacers and linking moieties. This patent represents a significant advancement in the creation of targeted therapies.

Career Highlights

Throughout her career, Ramona has demonstrated a strong commitment to research and innovation. She is currently associated with Araris Biotech AG, where she continues to explore new methodologies in drug development. Her work is characterized by a focus on improving the efficacy and specificity of therapeutic agents.

Collaborations

Ramona collaborates with notable colleagues, including Philipp Spycher and Philipp Probst. These partnerships enhance her research efforts and contribute to the advancement of biotechnology.

Conclusion

Ramona Stark is a trailblazer in the field of antibody-drug conjugates, with a patent that showcases her innovative approach to biotechnology. Her contributions are paving the way for new therapeutic strategies in medicine.